Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1407

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 1407
---
 Two Former Officers and Directors

On
September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase
and Release Agreement, dated September 18, 2023 (the “2023 Agreement”). Under the 2023 Agreement, the Company purchased for
surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “2023
Purchased Shares”) from sellers consisting of Mario Romano and Annette Raynor, two of the Company’s founders and former members
of management and the Board of Directors, and a series of their family members and related entities (collectively, the 2023 “Sellers”).
The 2023 Purchased Shares were purchased for aggregate consideration of $2,922,380, equating to a price of $0.00964739 per share, representing
a discount of approximately 52.5% to the average market price at the time of the closing. One-eighth of the purchase price was paid within
seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter.

In
addition to the cash consideration for the 2023 Purchased Shares, the Company also agreed to cover a limited amount of the legal fees
incurred by the 2023 Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable
in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in
which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor
agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or
otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

The
consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for
a total of $3,172,380.

Purchase
of Company Shares in a Private Transaction

On
February 7, 2024, we closed on the purchase in a private